Journal article
2011-03-01T00:00:00+00:00
29
e159 - e162
Adult, Angiogenesis Inhibitors, Antibodies, Monoclonal, Antibodies, Monoclonal, Humanized, Astrocytoma, Bevacizumab, Brain Neoplasms, Disease Progression, Dose-Response Relationship, Drug, Drug Administration Schedule, Follow-Up Studies, Humans, Male, Necrosis, Radiation Injuries, Risk Assessment, Severity of Illness Index, Treatment Outcome